drugset / Trial / NCT03138317

Evaluation of Platelet Rich Plasma (PRP) for Knee Osteoarthritis

NCT03138317

RandomizedParallel-groupTriple-blindTreatment

Summary

Study was designed to evaluate efficacy of autologous platelet rich plasma (PRP) injections guided by ultrasound for treatment of knee osteoarthritis.

Timeline

Start
2017-01-02
Primary completion
2018-05-30
Completion
2018-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject PRP Unknown 6 ml Other
Subject Plasma Other / unclassified 6 ml Other

Indications